184 related articles for article (PubMed ID: 29171692)
41. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
42. Molecular mechanism of plasmid-borne resistance to sulfonamide antibiotics.
Venkatesan M; Fruci M; Verellen LA; Skarina T; Mesa N; Flick R; Pham C; Mahadevan R; Stogios PJ; Savchenko A
Nat Commun; 2023 Jul; 14(1):4031. PubMed ID: 37419898
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.
Kovacs JA; Powell F; Voeller D; Allegra CJ
Antimicrob Agents Chemother; 1993 Jun; 37(6):1227-31. PubMed ID: 7687120
[TBL] [Abstract][Full Text] [Related]
44. Kinetic and structural characterization of a product complex of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Escherichia coli.
Garçon A; Bermingham A; Lian LY; Derrick JP
Biochem J; 2004 Jun; 380(Pt 3):867-73. PubMed ID: 15018613
[TBL] [Abstract][Full Text] [Related]
45. Large scale molecular dynamics simulation of native and mutant dihydropteroate synthase-sulphanilamide complexes suggests the molecular basis for dihydropteroate synthase drug resistance.
Giordanetto F; Fowler PW; Saqi M; Coveney PV
Philos Trans A Math Phys Eng Sci; 2005 Aug; 363(1833):2055-73. PubMed ID: 16099766
[TBL] [Abstract][Full Text] [Related]
46. Bisubstrate inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: Transition state analogs for high affinity binding.
Shi G; Shaw GX; Zhu F; Tarasov SG; Ji X
Bioorg Med Chem; 2021 Jan; 29():115847. PubMed ID: 33199204
[TBL] [Abstract][Full Text] [Related]
47. Analysis of random mutations in Salmonella Gallinarum dihydropteroate synthase conferring sulfonamide resistance.
Duysak T; Jeong JH; Kim K; Kim JS; Choy HE
Arch Microbiol; 2023 Oct; 205(12):363. PubMed ID: 37906281
[TBL] [Abstract][Full Text] [Related]
48. New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors.
Nasr T; Bondock S; Ibrahim TM; Fayad W; Ibrahim AB; AbdelAziz NA; Sakr TM
Bioorg Med Chem; 2020 May; 28(9):115444. PubMed ID: 32220521
[TBL] [Abstract][Full Text] [Related]
49. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
50. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):379-87. PubMed ID: 23627736
[TBL] [Abstract][Full Text] [Related]
51. Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.
Zhao Y; Hammoudeh D; Lin W; Das S; Yun MK; Li Z; Griffith E; Chen T; White SW; Lee RE
Bioconjug Chem; 2011 Oct; 22(10):2110-7. PubMed ID: 21916405
[TBL] [Abstract][Full Text] [Related]
52. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
Iliades P; Berglez J; Meshnick S; Macreadie I
Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
[TBL] [Abstract][Full Text] [Related]
53. Genetic basis for sulfonamide resistance in Bacillus anthracis.
Valderas MW; Bourne PC; Barrow WW
Microb Drug Resist; 2007; 13(1):11-20. PubMed ID: 17536929
[TBL] [Abstract][Full Text] [Related]
54. Cytosolic hydroxymethyldihydropterin pyrophosphokinase/dihydropteroate synthase from Arabidopsis thaliana: a specific role in early development and stress response.
Storozhenko S; Navarrete O; Ravanel S; De Brouwer V; Chaerle P; Zhang GF; Bastien O; Lambert W; Rébeillé F; Van Der Straeten D
J Biol Chem; 2007 Apr; 282(14):10749-61. PubMed ID: 17289662
[TBL] [Abstract][Full Text] [Related]
55. Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
Hevener KE; Zhao W; Ball DM; Babaoglu K; Qi J; White SW; Lee RE
J Chem Inf Model; 2009 Feb; 49(2):444-60. PubMed ID: 19434845
[TBL] [Abstract][Full Text] [Related]
56. Purification and partial characterization of 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase and 7,8-dihydropteroate synthase from Escherichia coli MC4100.
Talarico TL; Dev IK; Dallas WS; Ferone R; Ray PH
J Bacteriol; 1991 Nov; 173(21):7029-32. PubMed ID: 1657875
[TBL] [Abstract][Full Text] [Related]
57. The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.
Yun MK; Hoagland D; Kumar G; Waddell MB; Rock CO; Lee RE; White SW
Bioorg Med Chem; 2014 Apr; 22(7):2157-65. PubMed ID: 24613625
[TBL] [Abstract][Full Text] [Related]
58. Structure of
Shaw GX; Fan L; Cherry S; Shi G; Tropea JE; Ji X
Curr Res Struct Biol; 2023; 5():100095. PubMed ID: 36820301
[TBL] [Abstract][Full Text] [Related]
59. A proof-of-concept receptor-based assay for sulfonamides.
Liang X; Wang Z; Wang C; Wen K; Mi T; Zhang J; Zhang S
Anal Biochem; 2013 Jul; 438(2):110-6. PubMed ID: 23567760
[TBL] [Abstract][Full Text] [Related]
60. Dihydropteroate synthase based sensor for screening multi-sulfonamides residue and its comparison with broad-specific antibody based immunoassay by molecular modeling analysis.
Liang X; Li C; Zhu J; Song X; Yu W; Zhang J; Zhang S; Shen J; Wang Z
Anal Chim Acta; 2019 Mar; 1050():139-145. PubMed ID: 30661581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
